Amanda Berry
Acute Care · Atlanta, GANPI 1083651079
Payments from drug & device makers
Across 70 payments — averaging $32.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$349
- Abbott$316
- Heartflow, Inc.$291
- Boston Scientific$268
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$169
- Cvrx, Inc.$124
- plus $729 from 16 others
What the payments were for
- Food & beverage$2,246100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $349 |
| Abbott | 7 | $316 |
| Heartflow, Inc. | 5 | $291 |
| Boston Scientific | 4 | $268 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $169 |
| Cvrx, Inc. | 2 | $124 |
| AstraZeneca | 1 | $109 |
| Amgen(2 entities) | 7 | $103 |
| Scpharmaceuticals Inc. | 1 | $95 |
| Novartis | 3 | $86 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53 |
| Abiomed | 2 | $49 |
| Cequr Corporation | 2 | $43 |
| Philips North America LLC | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Kestra Medical Technology Services, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
| Impulse Dynamics (USA) Inc. | 1 | $19 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| AbbVie | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,246 in reported general payments places this provider in the 85th percentile of 679 acute care providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $30,873 |
| JardianceEmpagliflozin | 11 | $19,206 |
| Metoprolol Succinate | 29 | $385 |
| ClopidogrelClopidogrel Bisulfate | 31 | $369 |
| Atorvastatin Calcium | 35 | $369 |
| Spironolactone | 35 | $361 |
| Carvedilol | 27 | $280 |
| Rosuvastatin Calcium | 15 | $270 |
| Losartan Potassium | 23 | $259 |
| Furosemide | 31 | $161 |
| Metoprolol Tartrate | 22 | $141 |
| Amlodipine Besylate | 16 | $73 |
| Lisinopril | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Other acute care in Atlanta
- Sarah WymanAtlanta$10K
- Ayeshia PowellAtlanta$10K
- Michael WattsAtlanta$6K
- Merry NevilleAtlanta$5K
- Annalee EdwardsAtlanta$5K
- Jamie ThreattAtlanta$5K
- Kenya RaglandAtlanta$4K
- Emma HallAtlanta$4K
- Gretchen HallAtlanta$4K
- Summer DaviesAtlanta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.